Modulation of the Activity of the Cerebellum in Autism (MACA) (MACA)
Autism Spectrum Disorder
About this trial
This is an interventional basic science trial for Autism Spectrum Disorder focused on measuring tDCS, Cerebellum, neuromodulation, autism
Eligibility Criteria
Participant Inclusion/exclusion criteria: Participants must be more than 18 years old normal eyesight and hearing; Dutch, French or English speaking; Neurotypical participants inclusion/exclusion criteria: No disorder (now or in the past) that could have affected the brain such as cerebrovascular accidents (CVA), neurodegenerative disorders, or essential tremor; No neurological diseases that could affect reasoning or intellectual abilities (such as Parkinson's Disease, Epilepsy, and Multiple Sclerosis) Neurotypical participants will be matched on age and gender to the ASD population; ASD participants inclusion/exclusion criteria: Patients with a formal diagnosis of high-functioning ASD as determined by the clinical psychologist/psychiatrist.
Sites / Locations
- UZ BrusselRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Active Comparator
Sham Comparator
Active Comparator
Sham Comparator
Active Comparator
Sham Comparator
ASD_anodalstimulation
ASD_shamstimulation
NT_anodalstimulation
NT_shamstimulation
H-AQ_anodalstimulation
H-AQ_shamstimulation
ASD participant, anodal stimulation on the first session, sham stimulation on the second sesion
ASD participant, sham stimulation on the first session, anodal stimulation on the second sesion
Neurotypical participant, anodal stimulation on the first session, sham stimulation on the second sesion
Neurotypical participant, sham stimulation on the first session, anodal stimulation on the second sesion
non diagnosed autistic participant,anodal stimulation on the first session, sham stimulation on the second sesion
non diagnosed autistic participant, sham stimulation on the first session, anodal stimulation on the second sesion